Arterial Spin Labelling perfusion measurements in Prion Disease: relation with restricted diffusion
Enrico De Vita1,2, Andrew Melbourne3, Marie-Claire Porter4,5, David L Thomas6, Sebastien Ourselin3, Tarek Yousry1,2, Xavier Golay2, Rolf Jager1,2, Simon Mead4,5, and John S Thornton1,2

1Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, United Kingdom, 2Academic Neuroradiological Unit. Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, United Kingdom, 3Medical Physics and Biomedical Engineering, University College London, London, United Kingdom, 4National Prion Clinic, National Hospital for Neurology and Neurosurgery, London, United Kingdom, 5MRC Prion Unit, Department of Neurodegenerative Diseases, UCL Institute of Neurology, London, United Kingdom, 6Dementia Research Centre, UCL Institute of Neurology, London, United Kingdom

Synopsis

Perfusion in Prion disease has only been explored with SPECT, except in 2 single-case studies.

We aimed to evaluate perfusion abnormalities with ASL-MRI in prion patients and compare the findings with clinically diagnostic high b-value diffusion weighted MRI. We observed high correlation between diffusion abnormalities and hypoperfusion. ASL-MRI could help to shed light non-invasively on the neurovascular aspects of prion disease

Introduction and Purpose

Prion disease is a progressive, uniformly fatal neurodegenerative disease caused by the accumulation of abnormal prion proteins in the brain. Diffusion-weighted imaging (DWI) is one of the most sensitive MRI techniques for differential diagnosis of prion disease, often showing hyperintensities in basal ganglia and selected cortical regions, with high-b-value DWI being preferable1. Most perfusion studies in prion disease were performed with SPECT and described diffuse patterns of hypoperfusion, often matching the MRI findings2. Given the spatial-resolution limitations of SPECT, MRI measurements could aid in further characterising the progression of prion disease and its effect on local brain perfusion. However, the related literature is scarce with a single example of CBV estimation using Gadolinium-enhanced MRI perfusion3 and 2 single-case reports using arterial spin labelling (ASL)4-5. We aimed to evaluate perfusion abnormalities with ASL-MRI in prion patients and compare the findings with clinically diagnostic high b-value diffusion weighted MRI.

Materials and Methods

Six prion disease patients (2 sporadic CJD –sCJD, 3 inherited; median age 56 years, range 31-72,) and 13 healthy subjects (49, 38-75 years) were scanned after informed consent on a 3T Siemens Trio. DWI with b=3000 s/mm2 was performed with a 3-scan trace measurement (resolution 1x1x5 mm3). FAIR Q2TIPS pulsed ASL used a 8-segment 3DGRASE readout with background suppression6; parameters were: spatial resolution 3.75x3.75x5mm3; TR=4s; TI1/2=800/2000ms; 5-9 repetitions; single M0 image. B0-field maps were acquired for geometric distortion correction. Structural T1-weighted (T1W) acquisition used MPRAGE. All subjects were clinically evaluated with the MRC scale score, assessing a number of cognitive/functional domains (20=normal, decreasing with progression)7. Perfusion was quantified as in the ASL White paper8. Distortion corrected DWI images were affine-registered in ASL space. Areas of hyper-intensity were drawn on ASL-registered DWI images. T1-W images were simultaneously segmented/parcellated9, and a population group-wise space estimated10. By registering the ASL data to the group-template, a ‘normal perfusion’ template was obtained. Patients’ ROIs were ‘transformed’ to the group-template space, to compare individual patient ROI CBF to control values. To evaluate regional differences, CBF maps were also normalised setting mean cortical GM CBF to 50ml/100g/min (normCBF). CBF and normCBF were evaluated in 6 areas per hemisphere: frontal, temporal, parietal, occipital lobes, plus cingular and insular cortex. CBF and normCBF Z scores (based on controls standard deviation) were calculated for patients and are noted for Z≤-2.0.

Results

Patients details are in Figure 1. Figure 2 shows (a) healthy DWI images, (b),(c),(d) DWI and corresponding CBF for 3 patients, (e) mean control CBF. Figure 3 illustrates the main ROI findings. Patients had lower median cortical GM than controls. Patients 1 and 2 did not show focal abnormalities on DWI or structural imaging, nor obvious abnormalities or asymmetry on CBF. Patient 1 had high mean cortical GM compared vs controls. For patient 2, normCBF was low in parietal lobes. Patients 3, 4, 5 had clear hyperintensities on DWI. All these areas also showed reduced ADC. Qualitatively, the CBF maps showed hypoperfusion in the same areas, in some cases with an exact overlap; in other cases there was a slight mismatch (see Fig. 2b,c,d). Whilst cortical perfusion abnormalities were very obvious, basal ganglia hypoperfusion was slightly harder to detect on the CBF maps. Patient 3 (Fig. 2b) had normCBF reductions matching the overall observation of more prominent left hemisphere involvement. Patient 4 (Fig. 2c) had a severely abnormal CBF map, with very high CBF in the areas of hyperintense DWI (see caption). Patient 5 (Fig. 2d) showed low normCBF mostly in the left parietal and cingulate cortex.

Discussion and Conclusions

Prion patients often present with clear MRI signs at time of diagnosis, most often restricted diffusion on DWI. In some cases concomitant hypoperfusion assessed by SPECT has been reported11. We report ASL-CBF measurements on 5 prion patients. In cases with clear DWI hyperintensities, there were definite and well correlated CBF reductions. Manual delineation of ROIs confirmed visual assessment of CBF maps by providing comparison to control values. Evaluation of normCBF over the main cerebral lobes also helped to highlight diffuse perfusion deficiencies. The histological hallmarks of prion are spongiosis, neuronal loss and gliosis, the combination of which results in diffusion changes. Some investigators reported a non monotonous change in ADC in some patients12 probably reflecting the time-varying relative contribution of these mechanisms. ASL perfusion appears to be able to reproduce the previous finding obtained in prion disease with SPECT. Its non-invasive nature makes it viable for serial assessments and coupled with DWI it could allow further characterisation of the neurovascular aspects of the disease.

Acknowledgements

Part of this work was undertaken at UCLH/UCL who received a proportion of funding from the Department of Health’s NIHR Biomedical Research Centres funding scheme. DLT is supported by the UCL Leonard Wolfson Experimental Neurology Centre (PR/ylr/18575).

References

1. Hyare 2010, AJNR, 31:521.

2. Henkel 1999, J Neurol 1999; 246(S1): 490.

3. Romano 2007, Neuroradiolog 20(1):56.

4. Prasad 2010, J Neuro-Ophthalm; 30:1.

5. Chen 2015, J Clin Neuroscience; 22: 204.

6. Gunther 2005. MRM 54(2):491.

7. Thompson 2013, Brain, 136(Pt 4):1116.

8. Alsop 2014, MRM, 73(1):102.

9. Cardoso 2015, IEEE Trans Med Imaging, 34:1976.

10. Modat 2010, Comput Methods Programs Biomed, 98(3):278.

11. Na 1999 Arch Neurol, 56:951.

12. Tschampa 2003, AJNR, 24:908.

Figures

Details for the 5 prion patients. DWI hyperintensities were reported by an experienced neuroradiologist, alongside general observations

(a) Healthy subject DWI

(b) Patient 3. normCBF Z scores in ROIs: bilateral ant cing: z=-2; bilateral caud slightly decreased: -1.3; insula-L -2.7; posterior parietal ctx , L -2.3, R -1.15. Note DWI Fat artefact

(c) Patient 4. normCBF Z scores in ROIs: anterior cing, L -0.1, R -2.4; basal ganglia L -0.4, R -0.8; occipital ctx L -3.0, R, -2.9; bilateral parietal ctx -3.5. (d) Patient 5. normCBF Z scores in ROIs: caudate L -2.0, R -2.02; putamen L=-1.7, R=-1.6

(e) Mean control CBF map


Table 2. Main ROI findings, with cortical GM CBF values and Z scores for all lobes with at results for least one hemisphere considered to be significant (|z| >=2). Median cortical GM CBF were 38.8 and 31.6 ml/100g/min for controls and patients respectively. The top section show the Z scores. The middle section show control CBF values. The bottom section show the patient CBF values for the regions reported in the top section.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
1244